Predictions
Ocean Biomedical Inc.
Start price
Target price
Perf. (%)
€3.70
12.03.24
12.03.24
€7.50
12.03.25
12.03.25
0.00%
18.03.24
18.03.24
Could be very worthwhile Investment >20% year
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.22
12.03.24
12.03.24
-
12.03.25
12.03.25
-9.01%
16.03.24
16.03.24
Probably not worthwhile Investment
Delivery Hero SE
Start price
Target price
Perf. (%)
€25.10
11.03.24
11.03.24
€26.00
11.03.25
11.03.25
7.43%
12.03.24
12.03.24
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Tc Biopharm (holdings) Plc
Start price
Target price
Perf. (%)
€1.56
11.03.24
11.03.24
-
11.03.25
11.03.25
-13.46%
16.03.24
16.03.24
Probably not worthwhile Investment
Amazon.com Inc.
Start price
Target price
Perf. (%)
€159.98
10.03.24
10.03.24
€165.00
10.03.25
10.03.25
4.05%
28.03.24
28.03.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Encavis AG
Start price
Target price
Perf. (%)
€14.02
09.03.24
09.03.24
€21.00
09.03.25
09.03.25
19.91%
16.03.24
16.03.24
Could be very worthwhile Investment >20% year
Ballard Power Systems Inc.
Start price
Target price
Perf. (%)
€3.05
08.03.24
08.03.24
-
08.04.24
08.04.24
-3.28%
29.03.24
29.03.24
Very capable Management
Good culture
Sustainability is very important
Stable Large shareholder and/or long term investor
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€64.50
08.03.24
08.03.24
-
08.03.25
08.03.25
-8.53%
15.03.24
15.03.24
Could be worthwhile Investment >10% per year
Deutsche Rohstoff AG
Start price
Target price
Perf. (%)
€34.70
08.03.24
08.03.24
€35.00
08.03.25
08.03.25
6.92%
05.04.24
05.04.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Rising EBIT margin expected
Fair valuation
ProSiebenSat.1 Media SE
Start price
Target price
Perf. (%)
€6.56
08.03.24
08.03.24
€7.20
23.04.24
23.04.24
12.35%
12.04.24
12.04.24
Risky Investment
Microstrateg.a New
Start price
Target price
Perf. (%)
€1,181.0
08.03.24
08.03.24
-
08.04.24
08.04.24
18.37%
09.04.24
09.04.24
Could be worthwhile Investment >10% per year
Newmont Corp.
Start price
Target price
Perf. (%)
€31.80
07.03.24
07.03.24
€32.00
07.03.25
07.03.25
6.29%
29.03.24
29.03.24
Standard Investments for future growth
Capable Management
EBIT growth >5% per year expected
Higher EBIT margin than peer group
flatexDEGIRO AG
Start price
Target price
Perf. (%)
€9.56
07.03.24
07.03.24
€10.00
07.03.25
07.03.25
2.85%
14.03.24
14.03.24
EBIT growth > 30% per year expected
Known brand
Future proof or reliable business model
Higher EBIT margin than peer group
Delivery Hero SE
Start price
Target price
Perf. (%)
€23.75
06.03.24
06.03.24
€25.00
06.03.25
06.03.25
5.69%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Harmony Gold Mining
Start price
Target price
Perf. (%)
€6.32
06.03.24
06.03.24
€11.00
06.03.25
06.03.25
8.86%
16.03.24
16.03.24
EBIT growth >5% per year expected
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Silvercorp Metals Inc.
Start price
Target price
Perf. (%)
€2.42
06.03.24
06.03.24
€3.00
06.03.25
06.03.25
7.84%
16.03.24
16.03.24
Could be worthwhile Investment >10% per year
Capable Management
Revenue growth >5% per year expected
positive Cash Flow expected
Vizsla Silver Corp.
Start price
Target price
Perf. (%)
€1.06
06.03.24
06.03.24
€2.00
06.03.25
06.03.25
8.65%
16.03.24
16.03.24
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Fair valuation
Revenue growth >5% per year expected
U.S. Gold Corp.
Start price
Target price
Perf. (%)
€3.33
06.03.24
06.03.24
€5.00
06.03.25
06.03.25
3.30%
16.03.24
16.03.24
Higher EBIT margin than peer group
High dividend yield expected
Good rating
EBIT growth >5% per year expected
Aya Gold & Silver Inc.
Start price
Target price
Perf. (%)
€6.99
06.03.24
06.03.24
€15.00
06.03.25
06.03.25
10.44%
16.03.24
16.03.24
Higher EBIT margin than peer group
Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Xortx Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.75
06.03.24
06.03.24
-
06.03.25
06.03.25
-3.37%
16.03.24
16.03.24
Probably not worthwhile Investment
Albemarle Corp
Start price
Target price
Perf. (%)
€102.40
05.03.24
05.03.24
-
05.03.25
05.03.25
16.45%
03.04.24
03.04.24
Growths faster than the competition